The prevalence of obesity, diabetes, and new onset diabetes continue to grow…

The results of insulin release and glucose tolerance across a sample with declining kidney function… Insulin resistance is not uncommon to see when looking at patients with declining kidney function or chronic kidney disease (CKD). Insulin resistance progressively worsens with respect to kidney function decline. Although insulin resistance and chronic …

Diabetics who drink coffee had significantly lower HbA1c and higher adiponectin compared to those who did not… Researchers from India and Trinidad studied the levels of adiponectin in coffee drinkers for type 2 diabetes (DM2) and non-diabetic patients. This was a cross-sectional study including 220 non-diabetic subjects, 143 of who …

In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply… The Mount Sinai study found that harmine drove the sustained division and multiplication of adult human beta cells in culture. In addition, harmine treatment tripled the number of beta cells and …

Canagliflozin shows good results when compared to glimepiride in type 2 diabetes patients who were taking metformin.

Certain individuals may show detectable levels of C-peptide depending on time of diagnosis…

Lack of adequate sleep may be a risk factor… Researchers have attempted to determine how many hours of sleep are associated with the lowest risk of type 2 diabetes. The study was a meta-analysis and was performed to assess the relationship between sleep duration and the risk of type 2 …

Several demographic, clinical, and potentially modifiable system-level factors were associated with adherence to antidiabetic medications….

Australian researchers found a higher odds of eliminating symptoms of atrial fibrillation in obese patients who lost at least 10% of their body weight without undergoing surgery or medication than in those who failed to lose weight. The findings were presented at the American College of Cardiology meeting. — Journal …

The average lifetime medical cost for type 2 diabetes in the U.S. is $283,000, making it the most expensive place to have the condition, according to a review. Two out of three new diabetes cases occur in low- and middle-income countries such as Mexico, India and China. By 2035, 592 …